Wearable Injectors Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
Frequently asked questions about this report

Increased prevalence of chronic disorders such as pulmonary arterial hypertension, cardiovascular disease, cancer, Type 1 diabetes, rheumatoid arthritis, and autoimmune diseases along with other neurological diseases is increasing the growth of the Global Wearable Injectors Market.

This Global Wearable Injectors Market report is segmented by type, technology, application, end-users and geography.

Major players in the global wearable injectors market are Amgen, Inc., Becton, CeQur SA, Dickinson and Company, Johnson & Johnson Services, Inc., Enable Injections, F. Hoffmann-La Roche Ltd., Insulet Corporation, Unilife Corporation, SteadyMed Therapeutics, Inc., West Pharmaceutical Services, Inc., and Ypsomed.

The wearable injectors market size was estimated to be US$ 6.3 billion in 2021.

The global wearable injectors market is estimated to exhibit a CAGR of 11.5% between 2023 to 2032.

Due to the rising demand for user-friendly adhesive patches that allow patients to inject the drug subcutaneously, rapidly, and precisely by clicking on the device, the spring-based category has the greatest market size by technology.

Due to the obvious rising prevalence of chronic and lifestyle-related illnesses and the modernization of the healthcare system, North America is the biggest market by region, accounting for 41.5% of the overall industry share.